In an effort to boost global biopharma competitiveness, the U.K.’s National Institute for Health and Care Research (NIHR) has awarded £47.8 million ($64 million) to 51 National Health Service (NHS) healthcare providers and 79 primary care organizations to fund commercial research equipment.


